William L. Transier
About William L. Transier
Independent director at GoHealth appointed August 7, 2025; chairs Nominating & Corporate Governance, and serves on Audit and the special Transformation Committee created with the August 2025 financing package . He is Chairman of Helix Energy Solutions Group and CEO of Transier Advisors; prior roles include CFO of Ocean Energy and partner/KPMG Global Energy lead. Education: B.B.A. (University of Texas), M.B.A. (Regis University), M.A. in Theological Studies (Dallas Baptist University) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| KPMG LLP | Partner; Head, Global Energy | 1986–1996 | Led energy audit practice; deep accounting expertise |
| Ocean Energy, Inc. | Executive VP & CFO | 1996–2003 | Finance leadership; M&A integration experience |
| Endeavour International Corp. | Co-founder; Chairman, CEO & President | 2004–2014; Non-exec Chair 2014–2015 | Built and restructured international E&P operations |
External Roles
| Company | Role | Status | Notes |
|---|---|---|---|
| Helix Energy Solutions Group (NYSE: HLX) | Chairman of the Board | Current | Signed HLX S-3ASR as director (Oct 28, 2025) |
| Express, Inc. | Director | Current (since Apr 2024) | Board addition disclosed on Helix profile |
| Tupperware Corporation | Director | Current (since Oct 2023) | Board addition disclosed on Helix profile |
Board Governance
- Appointed to GoHealth Board August 7, 2025 amid debt amendments and a new “Transformation Committee” overseeing strategic alternatives and incentive plans .
- Committee assignments at GoHealth: Audit Committee member; Chair, Nominating & Corporate Governance; member, Transformation Committee .
- Independence: Not disclosed explicitly post-appointment; no related-party transactions reported with him in the appointment 8-K .
- Board refresh: Simultaneous resignations of three directors; governance oversight concentrated in Transformation Committee to evaluate refinancing, securitizations, M&A, restructurings .
Fixed Compensation
| Component | Amount | Notes |
|---|---|---|
| Annual cash retainer (non-employee director) | $150,000 | GoHealth director policy (2024) |
| Committee chair cash fees | Not specified | Policy details emphasize equity rather than chair cash fees |
| Meeting fees | None disclosed | No per-meeting fees in policy |
Performance Compensation
| Equity Component | Grant Value | Vesting | Notes |
|---|---|---|---|
| RSU award (Chair Director) | $250,000 | Four equal quarterly installments; accelerates on change of control | Annual grant policy |
| RSU award (Non-Chair Director) | $150,000 | Four equal quarterly installments; accelerates on change of control | Annual grant policy |
| Performance metrics tied to director equity | None disclosed | — | Director equity not performance-based; policy is time-vested |
Other Directorships & Interlocks
| Relationship | Nature | Potential Conflict |
|---|---|---|
| Helix Energy Solutions (Chairman) | Energy services; unrelated to Medicare brokerage | Low – different industry; no disclosed transactions with GoHealth |
| Express, Inc.; Tupperware | Retail companies | Low – unrelated to GoHealth’s business |
| Centerbridge/NVX (GoHealth controlling holders) | Not affiliated | No interlock; appointment arose with financing but no lender affiliation disclosed |
Expertise & Qualifications
- Financial expert (audit/accounting compliance), restructuring, M&A, international operations; extensive board leadership across distressed and complex situations .
- Education spans business and theology, supporting ethical governance and stewardship .
Equity Ownership
| Filing | Date | Disclosure | Notes |
|---|---|---|---|
| Form 3 (Initial Beneficial Ownership) | Aug 8, 2025 | Filed | Initial statement filed upon appointment; detailed holdings not present in retrieved summary |
Governance Assessment
- Committee leverage: As Audit Committee member and Nominating Chair, Transier strengthens board oversight and refresh processes; his restructuring pedigree aligns with GoHealth’s 2025 debt actions and strategic review mandate under the Transformation Committee .
- Independence & conflicts: No related-party ties disclosed; external boards are in unrelated industries, minimizing business conflicts. Time commitments should be monitored given concurrent chair role at Helix and multiple directorships .
- Director pay alignment: GoHealth’s policy mixes cash retainers with time-vested RSUs; change-of-control acceleration exists for directors, which is common but can raise optics during strategic reviews—investors should watch equity grants post-August 2025 given lender-driven governance changes .
- Signals: The August 2025 package (priming credit facility, board refresh, Transformation Committee) indicates a turn-around footing; Transier’s appointment is a confidence signal for operational and capital-structure oversight, but dilution and lender concessions heighten scrutiny on governance outcomes .